With $31m on hand at 30/06/22 and lets say another $15m from the recent Acadia payment and assume the below:
* US$40m upfront for ROW giving AUD$61m using a .65FX rate
* US$40m from first commercial sale of Trof per terms (assume received in May 2023) again say AUD$61m
Total cash comes to $168m. Take out R & D and employee costs of say $20m (prob overs) and we have a cash balance of approx $148m. I just wonder if we could end up with a special 30-40c divvy paying out $38-50m. Its almost certain we wont be funding any of the NNZ-2591 P3 trials and any future indications would still be able to be funded by us given we would still have approx $100m in the bank. I dont think we are far away from divs at all.
Share Price, page-2548
-
- There are more pages in this discussion • 8,884 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.48 |
Change
0.160(1.04%) |
Mkt cap ! $1.978B | |||
| Open | High | Low | Value | Volume |
| $15.10 | $15.48 | $15.04 | $6.154M | 402.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1498 | $15.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 8296 | 2 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |